PARP inhibitors as first-line maintenance therapy in ovarian cancer: Update from SGO 2022

touchPODCAST · Apr 20, 2022 · 57m

touchCONGRESS for touchONCOLOGY

Listen to Prof. Isabelle Ray-Coquard (France) cover key data presented at SGO 2022 on PARP inhibitors as first-line maintenance therapy in ovarian cancer, and their implications for clinical practice, including expert insights and interpretation from Dr Antonio González-Martín (Spain) and Dr Sandro Pignata (Italy).

OVERVIEW

Data review with Prof. Ray-Coquard (0:32)

Expert interviews with Dr González-Martín, Dr Pignata and

Prof. Ray-Coquard, answering the questions below

INTERVIEW QUESTIONS

How have the clinical trial data regarding first-line maintenance with…